Inventor
JENNIFA GOSLING
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes19%
C07DHeterocyclic compounds19%
C12NMicroorganisms or enzymes19%
A61NElectrotherapy8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
PatentTitleYear
12,594,263CBL inhibitors and compositions for expansion of immune cells202612,485,1443-substituted piperidine compounds for Cbl-b inhibition, and use thereof202512,234,230Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof202512,121,540CBL inhibitors and compositions for use in adoptive cell therapy202412,049,471Cyano cyclobutyl compounds for Cbl-b inhibition and uses thereof202411,951,1333-substituted piperidine compounds for Cbl-b inhibition, and use thereof202411,530,229Cyano cyclobutyl compounds for CBL-B inhibition and uses thereof202211,464,8023-substituted piperidine compounds for Cbl-b inhibition, and use thereof202211,401,267Substituted benzyl-triazole compounds for Cbl-b inhibition, and further uses thereof2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to NURIX THERAPEUTICS INC (9)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| NURIX THERAPEUTICS INC | 9 | 2022–2026 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2022–2026 |